As shown in Figures 5D, 5E, S8C, and 8D, both CD45+ immune cells (indicated leukocytes) and CD3+ immune cells (indicated T lymphocytes) within the tumor were significantly increased by ppM1 treatment compared to the untreated tumors. This evidence concerns the gene PTPRC and neoplasm.